| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 9 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.38M | - | |
| Other | 218.9K | $5.15M | - | |
| Other | 167.1K | $3.93M | -10,259 | |
| CFO | 118.3K | $2.78M | - | |
| VP | 62.3K | $1.46M | -6,115 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2015 | Longenecker John P Phd | Director | Sale+OE | 3,000 | $95.28 | $285,840.00 | -100% | |
| Feb 6, 2015 | Scibetta James S | SVP, Chief Financial Officer | Sale+OE | 15,000 | $111.22 | $1,668,374.19 | -28.2% | |
| Jan 15, 2015 | Stack David M67 | President, CEO And Chairman | Sale+OE | 15,000 | $97.52 | $1,462,829.00 | -61.2% | |
| Jan 12, 2015 | Hastings Paul J77 | Director | Sale+OE | 2,500 | $94.06 | $235,150.00 | -74.6% |